NeurGear, a forerunner in bioengineering technologies, is excited to announce that it has achieved ‘patent pending’ status, having submitted two provisional patents for its groundbreaking technology. This milestone is a significant step in solidifying NeurGear’s position at the forefront of the wellness technology industry.
One of the provisional patents is titled “Brainwave Entrainment Amplification”. This patent represents a pioneering concept in the field, further reflecting NeurGear’s commitment to innovation and its relentless pursuit of enhancing user well-being through advanced technology.
The patent submissions have been led by NeurGear’s esteemed CTO, Stanley Stephenson, who holds over 180 granted patents to his name. Stephenson’s expertise and profound knowledge in the field have been instrumental in developing and patenting the innovative technology underpinning NeurGear’s offerings.
“We are thrilled to have reached this ‘patent pending’ milestone,” said Stephenson. “This step not only reinforces our position as leaders in the field but also protects our unique technology, which is at the heart of everything we do at NeurGear.”
As NeurGear continues to advance its ZenBud device, the company is excited about the potential these patents bring to the table. They look forward to continued innovation and pushing the boundaries of what’s possible in the realm of wellness technology.
For more information about NeurGear and its patent-pending technology, please visit www.zenbud.health
About NeurGear NeurGear is a pioneering bioengineering company committed to creating innovative solutions for the wellness industry. With a steadfast focus on leveraging cutting-edge technology and user-focused design, NeurGear is at the vanguard of developing groundbreaking devices that improve the quality of life for its users.